LONDON (Reuters) - U.S. drug company Endo Pharmaceuticals' gel designed to prevent infection with the AIDS virus was ineffective in trials in Africa, Britain's Medical Research Council (MRC) said on ... Seeking Alpha: New Retrospective Data on African Americans with Advanced Symptomatic Sarcoidosis Treated with Acthar® Gel (Repository Corticotropin Injection) Presented at the American ...
Retrospective medical chart review subgroup analysis showed Acthar Gel was associated with overall symptom improvement and reduction in use of concomitant medications in African Americans This ad hoc ... New Retrospective Data on African Americans with Advanced Symptomatic Sarcoidosis Treated with Acthar® Gel (Repository Corticotropin Injection) Presented at the American ... Seeking Alpha: Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non ... – Retrospective analysis suggests Acthar Gel treatment was associated with similar improvement in health status and overall symptom reduction in African Americans and non-African Americans with ...
africa gel, Mallinckrodt Announces Journal Publication of Real-World Data on Acthar® Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non ... Arizona Daily Star: Anti-AIDS gel disappoints, failing to prevent HIV infection in study of African women The first anti-AIDS vaginal gel to make it through late-stage testing failed to stop HIV infection in a study of 6,000 South African women, disappointed researchers announced Monday. The study was ... Anti-AIDS gel disappoints, failing to prevent HIV infection in study of African women
